Subject: MJTV to Work With HealthPartners Institute for Education and Research

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJTV to Work With HealthPartners Institute for Education and Research
Hot Stock to WatchHot Stock to Watch

Company: Michael James Enterprises, Inc. (OTCQB: MJTV)


Price: 0.14

Change (%): + 0.00 (0.00)

Volume: 0
MJTV Chart

Michael James Enterprises Buys Assignment of Master Agreement to Work With HealthPartners Institute for Education and Research

SHORT HILLS, NJ-(Marketwired - Aug 11, 2016) - Michael James Enterprises, Inc. (OTCQB: MJTV) is pleased to report that MJTV has purchased all rights title and interest to a master advising agreement. This master agreement with HealthPartners now entitles MJTV to work with William H. Frey, II, PhD., who is an expert in intranasal delivery.

One of the largest medical research and education centers in the Midwest, HealthPartners Institute, helps transform health care in the Midwest region and across the nation. As part of HealthPartners integrated care system, the Institute uses research and education to advance the Triple Aim of improving health, experience and affordability for their members, patients and the community at large. HealthPartners Institute conducts health services, survey-based, behavioral intervention, clinical and basic science research with collaborators within HealthPartners and around the world. Our research strengths include:

  • Child and maternal health
  • Chronic disease/diabetes
  • Clinical research
  • Critical care
  • Health economics
  • Mental health
  • Neurosciences/Alzheimer’s and Parkinson’s disease
  • Oncology
  • Oral health/dentistry
William H. Frey, II, PhD., will serve as one of MJTV’s scientific advisors and provide scientific advising services on behalf of HealthPartners Institute. MJTV will retain all right and title to all documentation and work product from this relationship. MJTV expects to add many more top scientific and medical experts in the coming weeks and months building the highest quality minds to advise and work with MJTV.

Dr. William H. Frey, II is the Founder and Co-Director of the Alzheimer’s Research Center at Regions Hospital, Professor of Pharmaceutics and faculty member in Neurology, Oral Biology and Neuroscience at the University of Minnesota and consultant to the pharmaceutical and biotechnology industry. Dr. Frey’s non-invasive intranasal method for bypassing the blood-brain barrier to rapidly delivery and target therapeutic agents to the brain along the olfactory and trigeminal neural pathways while reducing systemic exposure and unwanted side effects has captured the interest of both pharmaceutical companies and neuroscientists.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks